Accuvest Global Advisors Regeneron Pharmaceuticals, Inc. Transaction History

Accuvest Global Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $1.16 Million - $1.41 Million	1,699 Added 235.32%	2,421 $1.99 Million
Q4 2022 Jan 12, 2023	BUY	$705.89 - $766.39 $282,356 - $306,556	400 Added 124.22%	722 $0
Q3 2022 Oct 20, 2022	SELL	$573.97 - $724.32 $175,634 - $221,641	-306 Reduced 48.73%	322 $222,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $26,320 - $35,464	-48 Reduced 7.1%	628 $371,000
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $108,311 - $127,114	182 Added 36.84%	676 $472,000
Q4 2021 Jan 28, 2022	BUY	$543.48 - $670.97 $11,956 - $14,761	22 Added 4.66%	494 $312,000
Q3 2021 Nov 03, 2021	BUY	$574.03 - $680.96 $270,942 - $321,413	472 New	472 $286,000

1,487

84.6M

1.29M

1.47M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $71.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

Stay updated on Accuvest Global Advisors with notifications on news.